Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-02-04

Clinical Trial Update: Pharmacokinetic and Therapeutic Adaptation of Linezolid in the Treatment of Multi-Resistant Tuberculosis [NA]

View source ↗

Summary

Completed clinical trial evaluating pharmacokinetics and dosing strategies of Linezolid for treatment of multi-drug resistant tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linezolid (Zyvox) (linezolid)

Snippet

Sponsor: Fondation Hôpital Saint-Joseph | Conditions: Tuberculosis | NA | Status: COMPLETED